Polyphenols may be a superior GLP-1 agonist choice
GLP-1 (glucagon-like peptide-1) agonists play a crucial role in regulating glucose metabolism, enhancing insulin secretion, and improving satiety. While pharmaceutical GLP-1 agonists like semaglutide and liraglutide are well-known, certain polyphenols also exhibit properties that can enhance GLP-1 secretion or activity. These compounds offer a natural alternative for managing metabolic conditions such as diabetes and obesity. Below are some clinically studied polyphenols with proven GLP-1 agonistic effects or GLP-1 secretion enhancement.
Quercetin stimulates GLP-1 secretion by acting on enteroendocrine L-cells in the gut. It also improves insulin sensitivity and reduces oxidative stress. Studies show quercetin enhances GLP-1 levels and improves glycemic control in diabetic patients. In addition to these benefits, quercetin is anti-inflammatory, reduces lipid peroxidation, and supports endothelial function.
Resveratrol activates AMPK (AMP-activated protein kinase), which indirectly enhances GLP-1 secretion and improves gut hormone signaling. Human trials have demonstrated improved insulin sensitivity and increased GLP-1 levels with resveratrol supplementation. Resveratrol also supports mitochondrial function, reduces inflammation, and has cardioprotective effects.
Epicatechins, found in green tea or cocoa, stimulate GLP-1 release via modulation of gut microbiota and improvement in intestinal health. Studies show improved glucose tolerance and increased GLP-1 secretion in individuals consuming epicatechin-rich foods. Additional benefits include enhanced vascular function and reduced oxidative stress.
Curcumin modulates GLP-1 secretion through its anti-inflammatory properties and by targeting intestinal L-cells. Trials using bioavailable formulations, such as CurcuRouge® used in ACEND, have shown enhanced GLP-1 levels and improved glycemic control. Curcumin also improves gut health, reduces systemic inflammation, and provides neuroprotective effects.
Proanthocyanidins, derived from grape seed extract, enhance gut-derived GLP-1 secretion by positively influencing gut microbiota and intestinal permeability. Proanthocyanidins are linked to improved insulin secretion and glycemic control in diabetic patients. They are also potent antioxidants and offer cardioprotective benefits.
Luteolin increases GLP-1 secretion via modulation of gut inflammation and oxidative stress in the intestinal environment. Both animal and human studies indicate significant improvements in glucose metabolism and gut hormone signaling. Luteolin is also neuroprotective and reduces systemic inflammation.
Thymoquinone, a key component of black cumin seed, stimulates GLP-1 release, possibly via the inhibition of oxidative stress and inflammation in the gut. Preliminary trials suggest enhanced GLP-1 secretion and improved glycemic outcomes in metabolic disorders. Thymoquinone is also anti-inflammatory and supports liver function.
Dihydromyricetin enhances GLP-1 secretion by promoting gut microbiota diversity and reducing inflammation. Animal studies suggest its potential in promoting glucose metabolism and GLP-1 signaling. It also improves liver health and reduces oxidative stress.
Polyphenols naturally stimulate GLP-1 secretion through multiple mechanisms. Many interact with gut microbiota, promoting the growth of beneficial bacteria that stimulate GLP-1 secretion. They reduce gut and systemic inflammation, creating an optimal environment for GLP-1 signaling. Polyphenols also directly or indirectly activate L-cells in the gut to produce GLP-1 and activate AMPK, a metabolic switch that enhances insulin sensitivity and promotes GLP-1 activity.
For individuals managing chronic inflammation, metabolic syndrome, or diabetes, ACEND’s carefully crafted blend of polyphenols, including quercetin, luteolin, curcumin, and proanthocyanidins, offers a strategic formulation to naturally enhance GLP-1 activity. The inclusion of bioavailable forms such as CurcuRouge® (curcumin) and highly concentrated extracts ensures maximum efficacy and therapeutic benefit.